Eiger BioPharmaceuticals • EIGR
Eiger BioPharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of drugs for serious, rare, and ultra-rare diseases with high unmet medical needs and no approved therapies.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. David Apelian, M.D.,PhD$2.5M
Market Cap • 10/04/20242000
(há 24 anos)
2014
(10 years ago)
NASDAQ
Listagem
Palo Alto
Sede • California56
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
EIGRSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.